-$23.6M
Net Activity
Institutions Holding
115
Popularity Rank
#4162
Avg Weight
0.12%
Total Value
$126.8M
115 institutions currently hold TOI, with 71 net buyers and 55 net sellers this quarter.
Institutional Moves (Q1 2026)
Neutral
Based on recent trading activity
Net Selling Institutions
55
Net Buying Institutions
71
Top 5 by Value
+$72.0M
Total Buy Value
$62.4M
Total Sell Value
71
Net Buyers
55
Net Sellers
1
Filings (90d)
$147K
Total Est. Value
23K shares
Planned Shares
| Filer | Filing Date | Est. Value |
|---|---|---|
| YALE PODNOS | 2026-07-14 | $147K |
Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。
No Schedule 13D/13G filings for this ticker
1
Filings (14d)
Oncology Institute (TOI) signed a $75 million term loan agreement with Orbimed on July 1, 2026. The loan carries an interest rate of SOFR plus 5.75% (with a 3% floor) and matures in 2031. The company used the proceeds, along with cash on hand, to repay $86 million of its existing 2027 convertible notes. The loan is secured by substantially all of the company's assets and includes a minimum net revenue covenant of $700 million.
View Full Filing (SEC EDGAR)The most-added stocks by 13F institutions this quarter
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter